ICD-10 Coding for Stage III Chronic Kidney Disease(E11.22U, I12.9U, N18.1)
Explore ICD-10 coding for stage 3 chronic kidney disease, including codes N18.30, N18.31, and N18.32. Learn about documentation requirements and coding tips.
Complete code families applicable to Stage III Chronic Kidney Disease
Compare key differences between these codes to ensure accurate selection
| Code | Description | When to Use | Key Documentation |
|---|---|---|---|
| N18.30 | Chronic kidney disease, stage 3 unspecified | Use when CKD stage 3 is documented but not further specified as 3a or 3b. |
|
| N18.31 | Chronic kidney disease, stage 3a | Use when CKD stage 3a is explicitly documented. |
|
| N18.32 | Chronic kidney disease, stage 3b | Use when CKD stage 3b is explicitly documented. |
|
Clinical Decision Support
Always review the patient's clinical documentation thoroughly. When in doubt, choose the more specific code and ensure documentation supports it.
Key Information
Essential facts and insights aboutStage III Chronic Kidney Disease
Alternative codes to consider when ruling out similar conditions
Documentation & Coding Risks
Avoid these common issues when documenting Stage III Chronic Kidney Disease.
Omitting eGFR values in documentation.
Impact
Clinical: Inaccurate assessment of kidney function., Regulatory: Non-compliance with documentation standards., Financial: Potential for incorrect billing and reimbursement.
Mitigation
Ensure eGFR is documented in every CKD assessment., Use templates that prompt for eGFR entry.
Using unspecified codes when specific staging is available.
Impact
Reimbursement: May affect risk adjustment factor (RAF) scores., Compliance: Non-compliance with ICD-10 specificity requirements., Data Quality: Reduces the accuracy of clinical data.
Mitigation
Always document and code the specific stage (3a or 3b) when possible.
CKD Staging
Impact
Risk of incorrect staging due to lack of specific documentation.
Mitigation
Implement mandatory eGFR documentation in EHR systems.